Dorsey Wright & Associates’s Nuvectis Pharma NVCT Stock Holding History

Dorsey Wright & Associates’s Portfolio NVCT Stock Details NVCT Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell
2023 Q3	$18K	Sell
2023 Q2	$23.1K	Buy